Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China
Background and Aims. We want to investigate whether a novel noninvasive marker is suitable for Chinese CHB patients. Methods. A total of 160 treatment-naïve CHB patients who underwent liver biopsy were enrolled in our study, and we assessed the diagnostic accuracies of GPR, aspartate transaminase-to...
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Wiley
2017-01-01
|
| Reeks: | Gastroenterology Research and Practice |
| Online toegang: | http://dx.doi.org/10.1155/2017/7089702 |
| _version_ | 1826819134399184896 |
|---|---|
| author | Tianyi Ren Huan Wang Ruihong Wu Junqi Niu |
| author_facet | Tianyi Ren Huan Wang Ruihong Wu Junqi Niu |
| author_sort | Tianyi Ren |
| collection | DOAJ |
| description | Background and Aims. We want to investigate whether a novel noninvasive marker is suitable for Chinese CHB patients. Methods. A total of 160 treatment-naïve CHB patients who underwent liver biopsy were enrolled in our study, and we assessed the diagnostic accuracies of GPR, aspartate transaminase-to-platelet ratio index (APRI), and the fibrosis index based on 4 factors (FIB-4) in them. Results. Of these 160 CHB patients, the numbers of F0, F1, F2, F3, and F4 are 34 (21.3%), 62 (38.8%), 18 (11.3%), 24 (15%), and 22 (13.8%), respectively. The area under the receiver operating characteristic curves (AUROC) of GPR for fibrosis (0.77 versus 0.70, P=0.03), significant fibrosis (0.70 versus 0.63, P=0.02), and extensive fibrosis (0.71 versus 0.64, P=0.02) were significantly higher than those of APRI. The AUROCs of GPR and Fib-4 for fibrosis (0.77 versus 0.75, P=0.14), significant fibrosis (0.70 versus 0.70, P=0.22), extensive fibrosis (0.71 versus 0.68, P=0.13), and cirrhosis (0.64 versus 0.67, P=0.24) were comparable. Conclusions. The GPR can be a routine laboratory marker to stage liver fibrosis in patients with CHB in China. |
| first_indexed | 2025-02-16T06:05:13Z |
| format | Article |
| id | doaj.art-b2ad36bcc37e4771ad07d0c86f6fbacf |
| institution | Directory Open Access Journal |
| issn | 1687-6121 1687-630X |
| language | English |
| last_indexed | 2025-02-16T06:05:13Z |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj.art-b2ad36bcc37e4771ad07d0c86f6fbacf2025-02-03T07:25:25ZengWileyGastroenterology Research and Practice1687-61211687-630X2017-01-01201710.1155/2017/70897027089702Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in ChinaTianyi Ren0Huan Wang1Ruihong Wu2Junqi Niu3Department of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, ChinaDepartment of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, ChinaDepartment of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, ChinaDepartment of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, ChinaBackground and Aims. We want to investigate whether a novel noninvasive marker is suitable for Chinese CHB patients. Methods. A total of 160 treatment-naïve CHB patients who underwent liver biopsy were enrolled in our study, and we assessed the diagnostic accuracies of GPR, aspartate transaminase-to-platelet ratio index (APRI), and the fibrosis index based on 4 factors (FIB-4) in them. Results. Of these 160 CHB patients, the numbers of F0, F1, F2, F3, and F4 are 34 (21.3%), 62 (38.8%), 18 (11.3%), 24 (15%), and 22 (13.8%), respectively. The area under the receiver operating characteristic curves (AUROC) of GPR for fibrosis (0.77 versus 0.70, P=0.03), significant fibrosis (0.70 versus 0.63, P=0.02), and extensive fibrosis (0.71 versus 0.64, P=0.02) were significantly higher than those of APRI. The AUROCs of GPR and Fib-4 for fibrosis (0.77 versus 0.75, P=0.14), significant fibrosis (0.70 versus 0.70, P=0.22), extensive fibrosis (0.71 versus 0.68, P=0.13), and cirrhosis (0.64 versus 0.67, P=0.24) were comparable. Conclusions. The GPR can be a routine laboratory marker to stage liver fibrosis in patients with CHB in China.http://dx.doi.org/10.1155/2017/7089702 |
| spellingShingle | Tianyi Ren Huan Wang Ruihong Wu Junqi Niu Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China Gastroenterology Research and Practice |
| title | Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China |
| title_full | Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China |
| title_fullStr | Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China |
| title_full_unstemmed | Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China |
| title_short | Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China |
| title_sort | gamma glutamyl transpeptidase to platelet ratio predicts significant liver fibrosis of chronic hepatitis b patients in china |
| url | http://dx.doi.org/10.1155/2017/7089702 |
| work_keys_str_mv | AT tianyiren gammaglutamyltranspeptidasetoplateletratiopredictssignificantliverfibrosisofchronichepatitisbpatientsinchina AT huanwang gammaglutamyltranspeptidasetoplateletratiopredictssignificantliverfibrosisofchronichepatitisbpatientsinchina AT ruihongwu gammaglutamyltranspeptidasetoplateletratiopredictssignificantliverfibrosisofchronichepatitisbpatientsinchina AT junqiniu gammaglutamyltranspeptidasetoplateletratiopredictssignificantliverfibrosisofchronichepatitisbpatientsinchina |